Acciona Mostostal Warszawa is part of the Acciona Capital Group.

Report No. 41_Conclusion of the Contract for the Extension and Reconstruction of the SPZZOZ Hospital Building in Gryfice

20 August 2018

The Management Board of Mostostal Warszawa S.A. ("Company") hereby informs that on 8 August 2018, the Company was notified by Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej in Gryfice on the selection of the Company as the best offer in proceedings on the Extension along with rebuilding of the SPZZOZ hospital building in Gryfice covering operating block, surgical, orthopedic and traumatic and surgical departments, central pharmacy, sterilization facility along with the equipment "Stage I - construction works with the installation of medical gases.

The offer submitted by the Company includes:

Contract value: PLN 29.99 million gross.

Construction deadline: 30.06.2020.

The warranty period of 60 months.

Due performance security: 5% of the contract value.

 

The decision on the selection of the best offer may be appealed against, which may be lodged within 5 days of the day on which the circumstances underlying the lodging of the offer were or could have been taken.

Legal basis:

Article 17 para. 1 of MAR Regulation.

 

Management Board of Mostostal Warszawa S.A. („Company”) hereby informs that on the 20 August 2018 the Company has signed an agreement with Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej in Gryfice for the execution of the: Extension along with rebuilding of the SPZZOZ hospital building in Gryfice covering operating block, surgical, orthopaedic and traumatic and surgical departments, central pharmacy, sterilization facility along with the equipment "Stage I - construction works with the installation of medical gases.

 

Contract value: PLN 29.99 million gross.

Construction deadline: 30.06.2020.

The warranty period of 60 months.

Payment term: 30 days from the date of receipt of the invoice.

Due performance security: 5% of the contract value.

 

Legal basis:

Article 17 para. 1 of MAR Regulation.